Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 months ago

Possible Interaction: Folic Acid Antagonists and Arachidonate

Research Papers that Mention the Interaction

Desensitization by AA and U46619 is suppressed by antagonists of the endoperoxide/Tx receptor sites.
Biochemical pharmacology  •  1988  |  View Paper
The ability of Ca2+ antagonists to inhibit arachidonate release by PAF in this tissue probably reflects interference with PAF binding to its receptor.
The Biochemical journal  •  1985  |  View Paper
Additionally, antagonists of cyclooxygenase activity prevented both the vasoconstricting and the vasodilating actions of NaA in normal and in diabetic arteries, respectively, as well as the PGI2 tone enhancement in vessels from diabetics.
European journal of pharmacology  •  1984  |  View Paper